DirectView’s CEO Roger Ralston Attends The Rodman & Renshaw 21st Annual Global Investment Conference Hosted by H.C. Wainwright &Co.
10 sept. 2019 11h29 HE
|
DirectView Holdings, Inc.
NEW YORK, NY, Sept. 10, 2019 (GLOBE NEWSWIRE) -- DirectView Holdings, Inc. (DIRV), a company focused on ownership and management of leading video and security technology companies, today announced...
Canbiola to Discuss its CBD Business and Strategy at H.C. Wainwright 21st Annual Global Investment Conference
09 sept. 2019 07h30 HE
|
Canbiola, Inc.
HICKSVILLE, NY, Sept. 09, 2019 (GLOBE NEWSWIRE) -- via NEWMEDIAWIRE – Canbiola, Inc. (OTCQB: CANB) (“Canbiola” or the “Company”), a developer, manufacturer, and seller of a variety of hemp-derived...
M2 Compliance to Sponsor Rodman & Renshaw 21st Annual Global Investment Conference
06 sept. 2019 17h19 HE
|
M2 Compliance
Los Angeles, CA, Sept. 06, 2019 (GLOBE NEWSWIRE) -- M2 Compliance ("M2"), a leading SEC registered filing agent, and financial printer will be proudly sponsoring the Rodman & Renshaw Conference,...
Interpace to Present at the 21st Annual Global Investment Conference Sponsored by H.C. Wainwright
06 sept. 2019 06h55 HE
|
Interpace Diagnostics Group, Inc.
PARSIPPANY, NJ, Sept. 06, 2019 (GLOBE NEWSWIRE) -- Interpace Diagnostics Group, Inc. (“Interpace” or the “Company”) (NASDAQ: IDXG) today announced that the Company will present at the upcoming 21st...
VBI Vaccines to Present at the H.C. Wainwright 21st Annual Global Investment Conference
05 sept. 2019 08h00 HE
|
VBI Vaccines, Inc.
CAMBRIDGE, Mass., Sept. 05, 2019 (GLOBE NEWSWIRE) -- VBI Vaccines Inc. (Nasdaq: VBIV) ("VBI"), a commercial-stage biopharmaceutical company developing next-generation infectious disease and...
InspireMD to Present at the H.C. Wainwright 20th Annual Global Investment Conference in New York City
04 sept. 2018 07h30 HE
|
InspireMD, Inc.
TEL AVIV, ISRAEL, Sept. 04, 2018 (GLOBE NEWSWIRE) -- via NEWMEDIAWIRE - InspireMD, Inc. (NYSE American: NSPR), developer of the CGuard™ Embolic Prevention System (EPS) for the prevention of stroke...
Galectin Therapeutics to Present at the Rodman & Renshaw 19th Annual Global Investment Conference
05 sept. 2017 08h30 HE
|
Galectin Therapeutics
NORCROSS, Ga., Sept. 05, 2017 (GLOBE NEWSWIRE) -- Galectin Therapeutics Inc. (NASDAQ:GALT), the leading developer of therapeutics that target galectin proteins, today announced that management will...